Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study

MLA

Ernesto Rodriguez-Ayala, et al. “Towards Precision Medicine: Defining and Characterizing Adipose Tissue Dysfunction to Identify Early Immunometabolic Risk in Symptom-Free Adults from the GEMM Family Study.” Adipocyte, vol. 9, no. 1, Jan. 2020, pp. 153–69. EBSCOhost, https://doi.org/10.1080/21623945.2020.1743116.

APA

Ernesto Rodriguez-Ayala, Esther C. Gallegos-Cabrales, Laura Gonzalez-Lopez, Hugo A. Laviada-Molina, Rocio A. Salinas-Osornio, Edna J. Nava-Gonzalez, Irene Leal-Berumen, Claudia Escudero-Lourdes, Fabiola Escalante-Araiza, Fatima A. Buenfil-Rello, Vanessa-Giselle Peschard, Antonio Laviada-Nagel, Eliud Silva, Rosa A. Veloz-Garza, Angelica Martinez-Hernandez, Francisco M. Barajas-Olmos, Fernanda Molina-Segui, Lucia Gonzalez-Ramirez, Rebeca Espadas-Olivera, … Raul A. Bastarrachea. (2020). Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study. Adipocyte, 9(1), 153–169. https://doi.org/10.1080/21623945.2020.1743116

Chicago

Ernesto Rodriguez-Ayala, Esther C. Gallegos-Cabrales, Laura Gonzalez-Lopez, Hugo A. Laviada-Molina, Rocio A. Salinas-Osornio, Edna J. Nava-Gonzalez, Irene Leal-Berumen, et al. 2020. “Towards Precision Medicine: Defining and Characterizing Adipose Tissue Dysfunction to Identify Early Immunometabolic Risk in Symptom-Free Adults from the GEMM Family Study.” Adipocyte 9 (1): 153–69. doi:10.1080/21623945.2020.1743116.